Bowmed Ibisqus

Name

Bowmed Ibisqus

Legal name

Bowmed Ibisqus Ltd

Website

https://bowmed.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Generic Injectable Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO), Infectious Disease Specialty Pharmaceuticals (Non-vaccine) (HLAIACAM)

Keywords

• Generic injectable medicines
• Pharmaceutical distribution
• NHS hospital supply
• Hospital antibiotics
• Aseptic injectable products

Headquarters

HQ city

Chirk

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Generic Injectable Medicines Sales: Revenue is generated through the sale of generic injectable pharmaceutical products including antibiotics (penicillins, cephalosporins, carbapenems), cardiovascular drugs, anaesthetics, and gastrointestinal medicines to NHS hospitals and private healthcare providers.
2. Distribution & Market Access Services: The company offers distribution support, market access consultancy, dossier trade and in-licensing, and product divestment services to pharmaceutical partners seeking UK market entry or expansion.
3. Product Licensing Agreements: Bowmed distributes products on behalf of Marketing Authorization Holders including Laboratórios Azevedo, Villerton Invest, Quimedical-Produtos Farmaceuticos, and Ibigen Srl, operating in an in-licensing model where products are launched under MA holder approval.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels4 records

Core offering

Bowmed Ibisqus supplies generic injectable pharmaceutical products to NHS hospitals and the UK private healthcare sector. Its portfolio spans antibacterial injectables (penicillins, cephalosporins, carbapenems, quinolones, macrolides, glycopeptides, lincosamides), gastrointestinal injectables (PPIs), cardiovascular drugs, anaesthesia agents, and analgesics, distributed in ampoule, vial, and ready-to-use infusion bag formats. The company also offers distribution support, market access consultancy, dossier trade and in-licensing, and product divestment services to pharmaceutical partners.

Product overview

Bowmed Ibisqus is a privately owned pharmaceutical company and a wholly owned subsidiary of the Ibigen Group (Italy), specialising in the supply of generic injectable medicines to NHS hospitals and the private healthcare sector. The company offers a broad portfolio of injectable antibacterial medicines including penicillins (Amoxicillin, Flucloxacillin, Co-amoxiclav), cephalosporins (Cefotaxime, Ceftazidime, Ceftriaxone, Cefuroxime), carbapenems (Meropenem, Ertapenem), quinolones (Levofloxacin, Ciprofloxacin), macrolides (Clarithromycin), and other antibiotics (Vancomycin, Teicoplanin, Clindamycin). The portfolio has expanded into Gastrointestinal (Esomeprazole, Omeprazole, Pantoprazole), Cardiovascular (Amiodarone, Labetalol, Dopamine, Tirofiban), and Anaesthesia (Levobupivacaine, Ropivacaine, Sugammadex, Rocuronium) therapeutic areas. Products are available in multiple formats: ampoules, vials, and ready-to-use infusion bags. The company also provides value-added services including distribution support, market access consultancy, dossier trade and in-licensing, and product divestment services. Business partners include AAH Pharmaco (distribution), Masters Global, AIT Worldwide Logistics (transport), Fannin Ireland (Irish market), TPS Healthcare Group, and Movianto (Northern Ireland supply chain).

Differentiator

Problem solved

Functional benefit

Products and services

• Antibacterial Injectable Medicines
• Gastrointestinal Injectable Medicines
• Cardiovascular Injectable Medicines
• Anaesthesia Injectable Medicines
• Analgesic Injectable Medicines
• Antifungal and Antiviral Injectable Medicines
• Distribution Support Services
• Market Access Consultancy Services
• Dossier Trade and In-Licensing Services
• Product Divestment Services

Quantifiable outcome

• Substantial budgetary savings for NHS while safeguarding patient care
• +2 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• Fannin IrelandcoreChannel Partner/ Reseller/ Distributor · 1 January 2018Partnership since 2018 to bring Bowmed's range of acute-care medicines to the Irish market, characterised by exceptional service, reliability, and partnership.
• TracelinkcoreTechnology or Integration · 1 January 2018Partnership between IBI Lorenzini and Tracelink to implement global serialisation solutions ahead of the February 2019 FMD deadline. The flexibility, scalability, speed and efficiency of Tracelink EU hub met the IBI group's stringent track and trace requirements.
• Ibigen GroupflagshipStrategic or Co-development PartnerBowmed Ibisqus is a wholly owned subsidiary of the Ibigen Group, headquartered in Italy. The group has over 100 years of experience producing and distributing injectable products worldwide, recognised for expertise in aseptic dosing and β-lactam formulations. The group operates as fully integrated, managing product development, regulatory registration, raw material sourcing, finished product manufacturing, and sales distribution.
• AAH PharmacocoreChannel Partner/ Reseller/ DistributorNominated distribution partner for Bowmed Ibisqus for several years, providing high level of service for Bowmed and ultimately for customers who use Bowmed products. The partnership strives to achieve the best possible standards.
• TPS Healthcare GroupcoreChannel Partner/ Reseller/ DistributorLong-standing strategic partnership for pre-wholesaler and distribution services throughout the UK for 18 years. The relationship ensures consistently high levels of service for supply of critical medicines to UK patients.
• Movianto Northern IrelandcoreChannel Partner/ Reseller/ DistributorPartnership for over 15 years providing reliable, proactive and collaborative supply chain solution for Northern Ireland. The Movianto team provides additional support to assist with unforeseen market demands.
• Masters GlobalminorChannel Partner/ Reseller/ DistributorPartnership focused on improving access across emerging markets. Masters Global values Bowmed's communication, proactiveness, engagement, and product quality.
• AIT Worldwide LogisticsminorOthersLong-standing transport company partner working with Bowmed for many years. AIT provides transport services ensuring products arrive to patients without changes to characteristics during transport, dealing with international supply chain challenges compliantly with forward planning.
• IntersyscoreTechnology or IntegrationDedicated cyber security provider maintaining Bowmed's certification and best practice standards. Provides 24/7 monitoring, threat detection, and incident response through a Security Operations Centre (SOC).
• UK Government Cyber Essentials SchemecoreOthersBowmed Ibisqus is an early adopter of the UK government's Cyber Essentials scheme, demonstrating long-standing commitment to foundational security controls as a proactive defence against common cyber threats.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Pfizer (Hospira): Global pharmaceutical incumbent with a leading generic injectable portfolio (formerly Hospira) sold broadly into NHS hospitals. A broader incumbent in the same category as Bowmed's products, providing competitive context on pricing and supply continuity.
• Sandoz (Novartis): World's largest generics company with a broad injectable portfolio, including antibiotics and hospital therapies. A broad incumbent competitor in the UK generic injectable category.
• Viatris (Mylan): Large global generic and specialty manufacturer with a significant injectable and biosimilar portfolio serving UK hospitals. Operates in the same generic injectable space as Bowmed but at much greater scale and breadth.

Direct peers

• Hikma Pharmaceuticals: Major global manufacturer and supplier of generic injectable medicines with a strong UK hospital footprint. Directly comparable to Bowmed Ibisqus in product category, target customer (NHS secondary care), and broad anti-infective / hospital therapy portfolio.
• hameln pharma: Specialist European generic injectable pharmaceutical company supplying hospital markets including the UK. Closely comparable business model (generic injectables for hospital secondary care) and therapeutic focus on anaesthesia, analgesia, and critical care.
• Flynn Pharma: UK-headquartered specialty pharmaceutical company focused on supplying niche and generic medicines to the NHS and private healthcare. Comparable as a UK-anchored, sales-and-distribution-led generic pharmaceutical company serving secondary care.
• Mercury Pharmaceuticals (Advanz Pharma): UK-based specialty pharmaceutical company focused on hospital and specialty care products, including injectables. Comparable in the UK secondary care channel and in-licensing/distribution-led model.
• Ethypharm (Martindale Pharma): European specialty and generic injectable company with strong UK hospital presence (formerly Martindale Pharma). Directly comparable in generic injectable portfolio and NHS secondary care customer base.

Others

• AAH Pharmaceuticals: UK's largest pharmaceutical distributor and Bowmed's nominated UK distribution partner. Comparable as a critical channel for Bowmed's products and as a participant in the same NHS secondary care supply chain.
• TPS Healthcare Group: UK pre-wholesaler and distribution partner of Bowmed Ibisqus for 18 years. Comparable as a long-tenured distribution channel serving UK hospital customers and as a benchmark for supply chain partnerships in this category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bowmed Ibisqus